Protein-Based Nanocarrier for Targeted Delivery of Drug for Cancer Therapy

Abstract

A healthy life is an essential right of any living thing. This health is affected by several factors and various diseases and disorders and affects the life of individuals. Cancer is an important disease affecting health, and its treatment is complex. These complex conventional treatments include surgical removal, chemotherapy, and radiotherapy, alone or in combination. With the increase in technologies in medical sciences, advancements are regularly improving therapy. These advancements include targeted therapies, stem cell therapies, ablation therapies, natural antioxidants, nanoparticulate drug delivery systems, chemo and sonodynamic therapies, and radionic therapies. Out of these therapies, nanoparticles are extensity evaluated for cancer therapies. These nanoparticles are used for the diagnosis and treatment of cancer. These nanoparticles include advantages of small scale. When prepared with biodegradative materials, these nanoparticles will be of great potential. When nanoparticle manufacturing, endogenous materials sharply reduce the immunogenicity and enhance the half-life and targeting of drugs to cancerous tissues. Drug targeting is a breakthrough innovation in chemotherapy leading to reduced cancer spread and reduced drug side effects on noncancerous cells. Newer technologies in targeted anticancer therapy are currently in research; some are in clinical trials, and some are approved. This chapter focuses on protein-based nanocarriers for the targeted delivery of drugs for cancer therapy and its brief aspects.